Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
114.33
-0.03 (-0.03%)
At close: Mar 6, 2026, 4:00 PM EST
114.28
-0.05 (-0.04%)
After-hours: Mar 6, 2026, 6:04 PM EST
Arcellx Employees
Arcellx had 209 employees as of December 31, 2025. The number of employees increased by 46 or 28.22% compared to the previous year.
Employees
209
Change (1Y)
46
Growth (1Y)
28.22%
Revenue / Employee
$106,632
Profits / Employee
-$1,095,378
Market Cap
6.69B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,769 |
| Cytokinetics | 673 |
| Rhythm Pharmaceuticals | 414 |
| CRISPR Therapeutics AG | 393 |
| Mirum Pharmaceuticals | 372 |
| Krystal Biotech | 295 |
| Cogent Biosciences | 258 |
| Kymera Therapeutics | 238 |
ACLX News
- 3 days ago - Top 2 Health Care Stocks That May Crash This Quarter - Benzinga
- 4 days ago - Baron Health Care Fund Q4 2025 Recent Activity - Seeking Alpha
- 4 days ago - Baron Health Care Fund Q4 2025 Contributors And Detractors - Seeking Alpha
- 11 days ago - Here's Why Shares of Arcellx Are Up Almost 80% Today - Investopedia
- 12 days ago - Why is Arcellx stock up 80% today? Gilead's $7.8B answer - Invezz
- 12 days ago - Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion - Reuters
- 12 days ago - Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion - WSJ
- 12 days ago - Gilead to acquire Arcellx for $7.8 billion - Reuters